Global NK Cells Market Growth 2025-2031
The global NK Cells market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Natural killer lymphocytes: NK cells for short, are differentiated from lymphocytes in the bone marrow, accounting for 2% to 5% of the total number of lymphocytes in the blood. NK cells are widely distributed in the human body, in peripheral blood and spleen. , NK cell activity is highest in lymph nodes. NK cells are present in the lamina propria of hollow organ walls and in the interstitium of some solid organs. NK cell activity is lower in bone marrow. NK cells are large lymphocytes with an average diameter of 12~15?m, with more cytoplasm, and many azurophilic granules of different sizes in the cytoplasm, so it is also called large granular lymphocyte (LGL). The nucleus is oval, and under the electron microscope, the cells are The azurophilic granules in the cytoplasm are lysosomes. The chromatin in the nucleus is rich, and heterochromatin is mostly at the edge. There are short microvilli on the cell surface. NK cells do not need antigen activation, let alone the assistance of antibodies. They can Directly killing target cells, such as virus-infected cells and tumor cells, the anti-infection and anti-tumor killing effects of NK cells are broad-spectrum.
United States market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key NK Cells players cover Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “NK Cells Industry Forecast” looks at past sales and reviews total world NK Cells sales in 2024, providing a comprehensive analysis by region and market sector of projected NK Cells sales for 2025 through 2031. With NK Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NK Cells industry.
This Insight Report provides a comprehensive analysis of the global NK Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NK Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NK Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NK Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NK Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of NK Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global NK Cells market?
What factors are driving NK Cells market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NK Cells market opportunities vary by end market size?
How does NK Cells break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Natural killer lymphocytes: NK cells for short, are differentiated from lymphocytes in the bone marrow, accounting for 2% to 5% of the total number of lymphocytes in the blood. NK cells are widely distributed in the human body, in peripheral blood and spleen. , NK cell activity is highest in lymph nodes. NK cells are present in the lamina propria of hollow organ walls and in the interstitium of some solid organs. NK cell activity is lower in bone marrow. NK cells are large lymphocytes with an average diameter of 12~15?m, with more cytoplasm, and many azurophilic granules of different sizes in the cytoplasm, so it is also called large granular lymphocyte (LGL). The nucleus is oval, and under the electron microscope, the cells are The azurophilic granules in the cytoplasm are lysosomes. The chromatin in the nucleus is rich, and heterochromatin is mostly at the edge. There are short microvilli on the cell surface. NK cells do not need antigen activation, let alone the assistance of antibodies. They can Directly killing target cells, such as virus-infected cells and tumor cells, the anti-infection and anti-tumor killing effects of NK cells are broad-spectrum.
United States market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for NK Cells is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key NK Cells players cover Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “NK Cells Industry Forecast” looks at past sales and reviews total world NK Cells sales in 2024, providing a comprehensive analysis by region and market sector of projected NK Cells sales for 2025 through 2031. With NK Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NK Cells industry.
This Insight Report provides a comprehensive analysis of the global NK Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NK Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NK Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NK Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NK Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of NK Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Mogamulizumab
- Lorvotuzumab Mertansine
- Others
- Cancer
- Cardiovascular Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chipscreen Biosciences
- Affimed NV
- Altor BioScience
- Innate Pharma
- Takeda
- Sorrento Therapeutics
- NantKwest
- Bristol-Myers Squibb
- NKT
- Henry Ford Health Services
- Fortress Biotech
What is the 10-year outlook for the global NK Cells market?
What factors are driving NK Cells market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NK Cells market opportunities vary by end market size?
How does NK Cells break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NK Cells Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for NK Cells by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for NK Cells by Country/Region, 2020, 2024 & 2031
2.2 NK Cells Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 NK Cells Sales by Type
2.3.1 Global NK Cells Sales Market Share by Type (2020-2025)
2.3.2 Global NK Cells Revenue and Market Share by Type (2020-2025)
2.3.3 Global NK Cells Sale Price by Type (2020-2025)
2.4 NK Cells Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 NK Cells Sales by Application
2.5.1 Global NK Cells Sale Market Share by Application (2020-2025)
2.5.2 Global NK Cells Revenue and Market Share by Application (2020-2025)
2.5.3 Global NK Cells Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global NK Cells Breakdown Data by Company
3.1.1 Global NK Cells Annual Sales by Company (2020-2025)
3.1.2 Global NK Cells Sales Market Share by Company (2020-2025)
3.2 Global NK Cells Annual Revenue by Company (2020-2025)
3.2.1 Global NK Cells Revenue by Company (2020-2025)
3.2.2 Global NK Cells Revenue Market Share by Company (2020-2025)
3.3 Global NK Cells Sale Price by Company
3.4 Key Manufacturers NK Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NK Cells Product Location Distribution
3.4.2 Players NK Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NK CELLS BY GEOGRAPHIC REGION
4.1 World Historic NK Cells Market Size by Geographic Region (2020-2025)
4.1.1 Global NK Cells Annual Sales by Geographic Region (2020-2025)
4.1.2 Global NK Cells Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic NK Cells Market Size by Country/Region (2020-2025)
4.2.1 Global NK Cells Annual Sales by Country/Region (2020-2025)
4.2.2 Global NK Cells Annual Revenue by Country/Region (2020-2025)
4.3 Americas NK Cells Sales Growth
4.4 APAC NK Cells Sales Growth
4.5 Europe NK Cells Sales Growth
4.6 Middle East & Africa NK Cells Sales Growth
5 AMERICAS
5.1 Americas NK Cells Sales by Country
5.1.1 Americas NK Cells Sales by Country (2020-2025)
5.1.2 Americas NK Cells Revenue by Country (2020-2025)
5.2 Americas NK Cells Sales by Type (2020-2025)
5.3 Americas NK Cells Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NK Cells Sales by Region
6.1.1 APAC NK Cells Sales by Region (2020-2025)
6.1.2 APAC NK Cells Revenue by Region (2020-2025)
6.2 APAC NK Cells Sales by Type (2020-2025)
6.3 APAC NK Cells Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe NK Cells by Country
7.1.1 Europe NK Cells Sales by Country (2020-2025)
7.1.2 Europe NK Cells Revenue by Country (2020-2025)
7.2 Europe NK Cells Sales by Type (2020-2025)
7.3 Europe NK Cells Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NK Cells by Country
8.1.1 Middle East & Africa NK Cells Sales by Country (2020-2025)
8.1.2 Middle East & Africa NK Cells Revenue by Country (2020-2025)
8.2 Middle East & Africa NK Cells Sales by Type (2020-2025)
8.3 Middle East & Africa NK Cells Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NK Cells
10.3 Manufacturing Process Analysis of NK Cells
10.4 Industry Chain Structure of NK Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NK Cells Distributors
11.3 NK Cells Customer
12 WORLD FORECAST REVIEW FOR NK CELLS BY GEOGRAPHIC REGION
12.1 Global NK Cells Market Size Forecast by Region
12.1.1 Global NK Cells Forecast by Region (2026-2031)
12.1.2 Global NK Cells Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global NK Cells Forecast by Type (2026-2031)
12.7 Global NK Cells Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Chipscreen Biosciences
13.1.1 Chipscreen Biosciences Company Information
13.1.2 Chipscreen Biosciences NK Cells Product Portfolios and Specifications
13.1.3 Chipscreen Biosciences NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Chipscreen Biosciences Main Business Overview
13.1.5 Chipscreen Biosciences Latest Developments
13.2 Affimed NV
13.2.1 Affimed NV Company Information
13.2.2 Affimed NV NK Cells Product Portfolios and Specifications
13.2.3 Affimed NV NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Affimed NV Main Business Overview
13.2.5 Affimed NV Latest Developments
13.3 Altor BioScience
13.3.1 Altor BioScience Company Information
13.3.2 Altor BioScience NK Cells Product Portfolios and Specifications
13.3.3 Altor BioScience NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Altor BioScience Main Business Overview
13.3.5 Altor BioScience Latest Developments
13.4 Innate Pharma
13.4.1 Innate Pharma Company Information
13.4.2 Innate Pharma NK Cells Product Portfolios and Specifications
13.4.3 Innate Pharma NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Innate Pharma Main Business Overview
13.4.5 Innate Pharma Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda NK Cells Product Portfolios and Specifications
13.5.3 Takeda NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Sorrento Therapeutics
13.6.1 Sorrento Therapeutics Company Information
13.6.2 Sorrento Therapeutics NK Cells Product Portfolios and Specifications
13.6.3 Sorrento Therapeutics NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sorrento Therapeutics Main Business Overview
13.6.5 Sorrento Therapeutics Latest Developments
13.7 NantKwest
13.7.1 NantKwest Company Information
13.7.2 NantKwest NK Cells Product Portfolios and Specifications
13.7.3 NantKwest NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 NantKwest Main Business Overview
13.7.5 NantKwest Latest Developments
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Information
13.8.2 Bristol-Myers Squibb NK Cells Product Portfolios and Specifications
13.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bristol-Myers Squibb Main Business Overview
13.8.5 Bristol-Myers Squibb Latest Developments
13.9 NKT
13.9.1 NKT Company Information
13.9.2 NKT NK Cells Product Portfolios and Specifications
13.9.3 NKT NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 NKT Main Business Overview
13.9.5 NKT Latest Developments
13.10 Henry Ford Health Services
13.10.1 Henry Ford Health Services Company Information
13.10.2 Henry Ford Health Services NK Cells Product Portfolios and Specifications
13.10.3 Henry Ford Health Services NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Henry Ford Health Services Main Business Overview
13.10.5 Henry Ford Health Services Latest Developments
13.11 Fortress Biotech
13.11.1 Fortress Biotech Company Information
13.11.2 Fortress Biotech NK Cells Product Portfolios and Specifications
13.11.3 Fortress Biotech NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fortress Biotech Main Business Overview
13.11.5 Fortress Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NK Cells Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for NK Cells by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for NK Cells by Country/Region, 2020, 2024 & 2031
2.2 NK Cells Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 NK Cells Sales by Type
2.3.1 Global NK Cells Sales Market Share by Type (2020-2025)
2.3.2 Global NK Cells Revenue and Market Share by Type (2020-2025)
2.3.3 Global NK Cells Sale Price by Type (2020-2025)
2.4 NK Cells Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 NK Cells Sales by Application
2.5.1 Global NK Cells Sale Market Share by Application (2020-2025)
2.5.2 Global NK Cells Revenue and Market Share by Application (2020-2025)
2.5.3 Global NK Cells Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global NK Cells Breakdown Data by Company
3.1.1 Global NK Cells Annual Sales by Company (2020-2025)
3.1.2 Global NK Cells Sales Market Share by Company (2020-2025)
3.2 Global NK Cells Annual Revenue by Company (2020-2025)
3.2.1 Global NK Cells Revenue by Company (2020-2025)
3.2.2 Global NK Cells Revenue Market Share by Company (2020-2025)
3.3 Global NK Cells Sale Price by Company
3.4 Key Manufacturers NK Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NK Cells Product Location Distribution
3.4.2 Players NK Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NK CELLS BY GEOGRAPHIC REGION
4.1 World Historic NK Cells Market Size by Geographic Region (2020-2025)
4.1.1 Global NK Cells Annual Sales by Geographic Region (2020-2025)
4.1.2 Global NK Cells Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic NK Cells Market Size by Country/Region (2020-2025)
4.2.1 Global NK Cells Annual Sales by Country/Region (2020-2025)
4.2.2 Global NK Cells Annual Revenue by Country/Region (2020-2025)
4.3 Americas NK Cells Sales Growth
4.4 APAC NK Cells Sales Growth
4.5 Europe NK Cells Sales Growth
4.6 Middle East & Africa NK Cells Sales Growth
5 AMERICAS
5.1 Americas NK Cells Sales by Country
5.1.1 Americas NK Cells Sales by Country (2020-2025)
5.1.2 Americas NK Cells Revenue by Country (2020-2025)
5.2 Americas NK Cells Sales by Type (2020-2025)
5.3 Americas NK Cells Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NK Cells Sales by Region
6.1.1 APAC NK Cells Sales by Region (2020-2025)
6.1.2 APAC NK Cells Revenue by Region (2020-2025)
6.2 APAC NK Cells Sales by Type (2020-2025)
6.3 APAC NK Cells Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe NK Cells by Country
7.1.1 Europe NK Cells Sales by Country (2020-2025)
7.1.2 Europe NK Cells Revenue by Country (2020-2025)
7.2 Europe NK Cells Sales by Type (2020-2025)
7.3 Europe NK Cells Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NK Cells by Country
8.1.1 Middle East & Africa NK Cells Sales by Country (2020-2025)
8.1.2 Middle East & Africa NK Cells Revenue by Country (2020-2025)
8.2 Middle East & Africa NK Cells Sales by Type (2020-2025)
8.3 Middle East & Africa NK Cells Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NK Cells
10.3 Manufacturing Process Analysis of NK Cells
10.4 Industry Chain Structure of NK Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NK Cells Distributors
11.3 NK Cells Customer
12 WORLD FORECAST REVIEW FOR NK CELLS BY GEOGRAPHIC REGION
12.1 Global NK Cells Market Size Forecast by Region
12.1.1 Global NK Cells Forecast by Region (2026-2031)
12.1.2 Global NK Cells Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global NK Cells Forecast by Type (2026-2031)
12.7 Global NK Cells Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Chipscreen Biosciences
13.1.1 Chipscreen Biosciences Company Information
13.1.2 Chipscreen Biosciences NK Cells Product Portfolios and Specifications
13.1.3 Chipscreen Biosciences NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Chipscreen Biosciences Main Business Overview
13.1.5 Chipscreen Biosciences Latest Developments
13.2 Affimed NV
13.2.1 Affimed NV Company Information
13.2.2 Affimed NV NK Cells Product Portfolios and Specifications
13.2.3 Affimed NV NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Affimed NV Main Business Overview
13.2.5 Affimed NV Latest Developments
13.3 Altor BioScience
13.3.1 Altor BioScience Company Information
13.3.2 Altor BioScience NK Cells Product Portfolios and Specifications
13.3.3 Altor BioScience NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Altor BioScience Main Business Overview
13.3.5 Altor BioScience Latest Developments
13.4 Innate Pharma
13.4.1 Innate Pharma Company Information
13.4.2 Innate Pharma NK Cells Product Portfolios and Specifications
13.4.3 Innate Pharma NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Innate Pharma Main Business Overview
13.4.5 Innate Pharma Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda NK Cells Product Portfolios and Specifications
13.5.3 Takeda NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Sorrento Therapeutics
13.6.1 Sorrento Therapeutics Company Information
13.6.2 Sorrento Therapeutics NK Cells Product Portfolios and Specifications
13.6.3 Sorrento Therapeutics NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sorrento Therapeutics Main Business Overview
13.6.5 Sorrento Therapeutics Latest Developments
13.7 NantKwest
13.7.1 NantKwest Company Information
13.7.2 NantKwest NK Cells Product Portfolios and Specifications
13.7.3 NantKwest NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 NantKwest Main Business Overview
13.7.5 NantKwest Latest Developments
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Information
13.8.2 Bristol-Myers Squibb NK Cells Product Portfolios and Specifications
13.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bristol-Myers Squibb Main Business Overview
13.8.5 Bristol-Myers Squibb Latest Developments
13.9 NKT
13.9.1 NKT Company Information
13.9.2 NKT NK Cells Product Portfolios and Specifications
13.9.3 NKT NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 NKT Main Business Overview
13.9.5 NKT Latest Developments
13.10 Henry Ford Health Services
13.10.1 Henry Ford Health Services Company Information
13.10.2 Henry Ford Health Services NK Cells Product Portfolios and Specifications
13.10.3 Henry Ford Health Services NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Henry Ford Health Services Main Business Overview
13.10.5 Henry Ford Health Services Latest Developments
13.11 Fortress Biotech
13.11.1 Fortress Biotech Company Information
13.11.2 Fortress Biotech NK Cells Product Portfolios and Specifications
13.11.3 Fortress Biotech NK Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fortress Biotech Main Business Overview
13.11.5 Fortress Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. NK Cells Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. NK Cells Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Mogamulizumab
Table 4. Major Players of Lorvotuzumab Mertansine
Table 5. Major Players of Others
Table 6. Global NK Cells Sales by Type (2020-2025) & (g)
Table 7. Global NK Cells Sales Market Share by Type (2020-2025)
Table 8. Global NK Cells Revenue by Type (2020-2025) & ($ million)
Table 9. Global NK Cells Revenue Market Share by Type (2020-2025)
Table 10. Global NK Cells Sale Price by Type (2020-2025) & (USD/g)
Table 11. Global NK Cells Sale by Application (2020-2025) & (g)
Table 12. Global NK Cells Sale Market Share by Application (2020-2025)
Table 13. Global NK Cells Revenue by Application (2020-2025) & ($ million)
Table 14. Global NK Cells Revenue Market Share by Application (2020-2025)
Table 15. Global NK Cells Sale Price by Application (2020-2025) & (USD/g)
Table 16. Global NK Cells Sales by Company (2020-2025) & (g)
Table 17. Global NK Cells Sales Market Share by Company (2020-2025)
Table 18. Global NK Cells Revenue by Company (2020-2025) & ($ millions)
Table 19. Global NK Cells Revenue Market Share by Company (2020-2025)
Table 20. Global NK Cells Sale Price by Company (2020-2025) & (USD/g)
Table 21. Key Manufacturers NK Cells Producing Area Distribution and Sales Area
Table 22. Players NK Cells Products Offered
Table 23. NK Cells Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global NK Cells Sales by Geographic Region (2020-2025) & (g)
Table 27. Global NK Cells Sales Market Share Geographic Region (2020-2025)
Table 28. Global NK Cells Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global NK Cells Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global NK Cells Sales by Country/Region (2020-2025) & (g)
Table 31. Global NK Cells Sales Market Share by Country/Region (2020-2025)
Table 32. Global NK Cells Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global NK Cells Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas NK Cells Sales by Country (2020-2025) & (g)
Table 35. Americas NK Cells Sales Market Share by Country (2020-2025)
Table 36. Americas NK Cells Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas NK Cells Sales by Type (2020-2025) & (g)
Table 38. Americas NK Cells Sales by Application (2020-2025) & (g)
Table 39. APAC NK Cells Sales by Region (2020-2025) & (g)
Table 40. APAC NK Cells Sales Market Share by Region (2020-2025)
Table 41. APAC NK Cells Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC NK Cells Sales by Type (2020-2025) & (g)
Table 43. APAC NK Cells Sales by Application (2020-2025) & (g)
Table 44. Europe NK Cells Sales by Country (2020-2025) & (g)
Table 45. Europe NK Cells Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe NK Cells Sales by Type (2020-2025) & (g)
Table 47. Europe NK Cells Sales by Application (2020-2025) & (g)
Table 48. Middle East & Africa NK Cells Sales by Country (2020-2025) & (g)
Table 49. Middle East & Africa NK Cells Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa NK Cells Sales by Type (2020-2025) & (g)
Table 51. Middle East & Africa NK Cells Sales by Application (2020-2025) & (g)
Table 52. Key Market Drivers & Growth Opportunities of NK Cells
Table 53. Key Market Challenges & Risks of NK Cells
Table 54. Key Industry Trends of NK Cells
Table 55. NK Cells Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. NK Cells Distributors List
Table 58. NK Cells Customer List
Table 59. Global NK Cells Sales Forecast by Region (2026-2031) & (g)
Table 60. Global NK Cells Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas NK Cells Sales Forecast by Country (2026-2031) & (g)
Table 62. Americas NK Cells Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC NK Cells Sales Forecast by Region (2026-2031) & (g)
Table 64. APAC NK Cells Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe NK Cells Sales Forecast by Country (2026-2031) & (g)
Table 66. Europe NK Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa NK Cells Sales Forecast by Country (2026-2031) & (g)
Table 68. Middle East & Africa NK Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global NK Cells Sales Forecast by Type (2026-2031) & (g)
Table 70. Global NK Cells Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global NK Cells Sales Forecast by Application (2026-2031) & (g)
Table 72. Global NK Cells Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Chipscreen Biosciences Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 74. Chipscreen Biosciences NK Cells Product Portfolios and Specifications
Table 75. Chipscreen Biosciences NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 76. Chipscreen Biosciences Main Business
Table 77. Chipscreen Biosciences Latest Developments
Table 78. Affimed NV Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 79. Affimed NV NK Cells Product Portfolios and Specifications
Table 80. Affimed NV NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 81. Affimed NV Main Business
Table 82. Affimed NV Latest Developments
Table 83. Altor BioScience Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 84. Altor BioScience NK Cells Product Portfolios and Specifications
Table 85. Altor BioScience NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 86. Altor BioScience Main Business
Table 87. Altor BioScience Latest Developments
Table 88. Innate Pharma Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 89. Innate Pharma NK Cells Product Portfolios and Specifications
Table 90. Innate Pharma NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 91. Innate Pharma Main Business
Table 92. Innate Pharma Latest Developments
Table 93. Takeda Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 94. Takeda NK Cells Product Portfolios and Specifications
Table 95. Takeda NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 96. Takeda Main Business
Table 97. Takeda Latest Developments
Table 98. Sorrento Therapeutics Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 99. Sorrento Therapeutics NK Cells Product Portfolios and Specifications
Table 100. Sorrento Therapeutics NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 101. Sorrento Therapeutics Main Business
Table 102. Sorrento Therapeutics Latest Developments
Table 103. NantKwest Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 104. NantKwest NK Cells Product Portfolios and Specifications
Table 105. NantKwest NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 106. NantKwest Main Business
Table 107. NantKwest Latest Developments
Table 108. Bristol-Myers Squibb Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 109. Bristol-Myers Squibb NK Cells Product Portfolios and Specifications
Table 110. Bristol-Myers Squibb NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 111. Bristol-Myers Squibb Main Business
Table 112. Bristol-Myers Squibb Latest Developments
Table 113. NKT Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 114. NKT NK Cells Product Portfolios and Specifications
Table 115. NKT NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 116. NKT Main Business
Table 117. NKT Latest Developments
Table 118. Henry Ford Health Services Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 119. Henry Ford Health Services NK Cells Product Portfolios and Specifications
Table 120. Henry Ford Health Services NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 121. Henry Ford Health Services Main Business
Table 122. Henry Ford Health Services Latest Developments
Table 123. Fortress Biotech Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 124. Fortress Biotech NK Cells Product Portfolios and Specifications
Table 125. Fortress Biotech NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 126. Fortress Biotech Main Business
Table 127. Fortress Biotech Latest Developments
Table 1. NK Cells Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. NK Cells Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Mogamulizumab
Table 4. Major Players of Lorvotuzumab Mertansine
Table 5. Major Players of Others
Table 6. Global NK Cells Sales by Type (2020-2025) & (g)
Table 7. Global NK Cells Sales Market Share by Type (2020-2025)
Table 8. Global NK Cells Revenue by Type (2020-2025) & ($ million)
Table 9. Global NK Cells Revenue Market Share by Type (2020-2025)
Table 10. Global NK Cells Sale Price by Type (2020-2025) & (USD/g)
Table 11. Global NK Cells Sale by Application (2020-2025) & (g)
Table 12. Global NK Cells Sale Market Share by Application (2020-2025)
Table 13. Global NK Cells Revenue by Application (2020-2025) & ($ million)
Table 14. Global NK Cells Revenue Market Share by Application (2020-2025)
Table 15. Global NK Cells Sale Price by Application (2020-2025) & (USD/g)
Table 16. Global NK Cells Sales by Company (2020-2025) & (g)
Table 17. Global NK Cells Sales Market Share by Company (2020-2025)
Table 18. Global NK Cells Revenue by Company (2020-2025) & ($ millions)
Table 19. Global NK Cells Revenue Market Share by Company (2020-2025)
Table 20. Global NK Cells Sale Price by Company (2020-2025) & (USD/g)
Table 21. Key Manufacturers NK Cells Producing Area Distribution and Sales Area
Table 22. Players NK Cells Products Offered
Table 23. NK Cells Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global NK Cells Sales by Geographic Region (2020-2025) & (g)
Table 27. Global NK Cells Sales Market Share Geographic Region (2020-2025)
Table 28. Global NK Cells Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global NK Cells Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global NK Cells Sales by Country/Region (2020-2025) & (g)
Table 31. Global NK Cells Sales Market Share by Country/Region (2020-2025)
Table 32. Global NK Cells Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global NK Cells Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas NK Cells Sales by Country (2020-2025) & (g)
Table 35. Americas NK Cells Sales Market Share by Country (2020-2025)
Table 36. Americas NK Cells Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas NK Cells Sales by Type (2020-2025) & (g)
Table 38. Americas NK Cells Sales by Application (2020-2025) & (g)
Table 39. APAC NK Cells Sales by Region (2020-2025) & (g)
Table 40. APAC NK Cells Sales Market Share by Region (2020-2025)
Table 41. APAC NK Cells Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC NK Cells Sales by Type (2020-2025) & (g)
Table 43. APAC NK Cells Sales by Application (2020-2025) & (g)
Table 44. Europe NK Cells Sales by Country (2020-2025) & (g)
Table 45. Europe NK Cells Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe NK Cells Sales by Type (2020-2025) & (g)
Table 47. Europe NK Cells Sales by Application (2020-2025) & (g)
Table 48. Middle East & Africa NK Cells Sales by Country (2020-2025) & (g)
Table 49. Middle East & Africa NK Cells Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa NK Cells Sales by Type (2020-2025) & (g)
Table 51. Middle East & Africa NK Cells Sales by Application (2020-2025) & (g)
Table 52. Key Market Drivers & Growth Opportunities of NK Cells
Table 53. Key Market Challenges & Risks of NK Cells
Table 54. Key Industry Trends of NK Cells
Table 55. NK Cells Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. NK Cells Distributors List
Table 58. NK Cells Customer List
Table 59. Global NK Cells Sales Forecast by Region (2026-2031) & (g)
Table 60. Global NK Cells Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas NK Cells Sales Forecast by Country (2026-2031) & (g)
Table 62. Americas NK Cells Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC NK Cells Sales Forecast by Region (2026-2031) & (g)
Table 64. APAC NK Cells Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe NK Cells Sales Forecast by Country (2026-2031) & (g)
Table 66. Europe NK Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa NK Cells Sales Forecast by Country (2026-2031) & (g)
Table 68. Middle East & Africa NK Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global NK Cells Sales Forecast by Type (2026-2031) & (g)
Table 70. Global NK Cells Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global NK Cells Sales Forecast by Application (2026-2031) & (g)
Table 72. Global NK Cells Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Chipscreen Biosciences Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 74. Chipscreen Biosciences NK Cells Product Portfolios and Specifications
Table 75. Chipscreen Biosciences NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 76. Chipscreen Biosciences Main Business
Table 77. Chipscreen Biosciences Latest Developments
Table 78. Affimed NV Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 79. Affimed NV NK Cells Product Portfolios and Specifications
Table 80. Affimed NV NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 81. Affimed NV Main Business
Table 82. Affimed NV Latest Developments
Table 83. Altor BioScience Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 84. Altor BioScience NK Cells Product Portfolios and Specifications
Table 85. Altor BioScience NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 86. Altor BioScience Main Business
Table 87. Altor BioScience Latest Developments
Table 88. Innate Pharma Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 89. Innate Pharma NK Cells Product Portfolios and Specifications
Table 90. Innate Pharma NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 91. Innate Pharma Main Business
Table 92. Innate Pharma Latest Developments
Table 93. Takeda Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 94. Takeda NK Cells Product Portfolios and Specifications
Table 95. Takeda NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 96. Takeda Main Business
Table 97. Takeda Latest Developments
Table 98. Sorrento Therapeutics Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 99. Sorrento Therapeutics NK Cells Product Portfolios and Specifications
Table 100. Sorrento Therapeutics NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 101. Sorrento Therapeutics Main Business
Table 102. Sorrento Therapeutics Latest Developments
Table 103. NantKwest Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 104. NantKwest NK Cells Product Portfolios and Specifications
Table 105. NantKwest NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 106. NantKwest Main Business
Table 107. NantKwest Latest Developments
Table 108. Bristol-Myers Squibb Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 109. Bristol-Myers Squibb NK Cells Product Portfolios and Specifications
Table 110. Bristol-Myers Squibb NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 111. Bristol-Myers Squibb Main Business
Table 112. Bristol-Myers Squibb Latest Developments
Table 113. NKT Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 114. NKT NK Cells Product Portfolios and Specifications
Table 115. NKT NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 116. NKT Main Business
Table 117. NKT Latest Developments
Table 118. Henry Ford Health Services Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 119. Henry Ford Health Services NK Cells Product Portfolios and Specifications
Table 120. Henry Ford Health Services NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 121. Henry Ford Health Services Main Business
Table 122. Henry Ford Health Services Latest Developments
Table 123. Fortress Biotech Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 124. Fortress Biotech NK Cells Product Portfolios and Specifications
Table 125. Fortress Biotech NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 126. Fortress Biotech Main Business
Table 127. Fortress Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of NK Cells
Figure 2. NK Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NK Cells Sales Growth Rate 2020-2031 (g)
Figure 7. Global NK Cells Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. NK Cells Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. NK Cells Sales Market Share by Country/Region (2024)
Figure 10. NK Cells Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Mogamulizumab
Figure 12. Product Picture of Lorvotuzumab Mertansine
Figure 13. Product Picture of Others
Figure 14. Global NK Cells Sales Market Share by Type in 2025
Figure 15. Global NK Cells Revenue Market Share by Type (2020-2025)
Figure 16. NK Cells Consumed in Cancer
Figure 17. Global NK Cells Market: Cancer (2020-2025) & (g)
Figure 18. NK Cells Consumed in Cardiovascular Diseases
Figure 19. Global NK Cells Market: Cardiovascular Diseases (2020-2025) & (g)
Figure 20. NK Cells Consumed in Others
Figure 21. Global NK Cells Market: Others (2020-2025) & (g)
Figure 22. Global NK Cells Sale Market Share by Application (2024)
Figure 23. Global NK Cells Revenue Market Share by Application in 2025
Figure 24. NK Cells Sales by Company in 2025 (g)
Figure 25. Global NK Cells Sales Market Share by Company in 2025
Figure 26. NK Cells Revenue by Company in 2025 ($ millions)
Figure 27. Global NK Cells Revenue Market Share by Company in 2025
Figure 28. Global NK Cells Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global NK Cells Revenue Market Share by Geographic Region in 2025
Figure 30. Americas NK Cells Sales 2020-2025 (g)
Figure 31. Americas NK Cells Revenue 2020-2025 ($ millions)
Figure 32. APAC NK Cells Sales 2020-2025 (g)
Figure 33. APAC NK Cells Revenue 2020-2025 ($ millions)
Figure 34. Europe NK Cells Sales 2020-2025 (g)
Figure 35. Europe NK Cells Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa NK Cells Sales 2020-2025 (g)
Figure 37. Middle East & Africa NK Cells Revenue 2020-2025 ($ millions)
Figure 38. Americas NK Cells Sales Market Share by Country in 2025
Figure 39. Americas NK Cells Revenue Market Share by Country (2020-2025)
Figure 40. Americas NK Cells Sales Market Share by Type (2020-2025)
Figure 41. Americas NK Cells Sales Market Share by Application (2020-2025)
Figure 42. United States NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC NK Cells Sales Market Share by Region in 2025
Figure 47. APAC NK Cells Revenue Market Share by Region (2020-2025)
Figure 48. APAC NK Cells Sales Market Share by Type (2020-2025)
Figure 49. APAC NK Cells Sales Market Share by Application (2020-2025)
Figure 50. China NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 54. India NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe NK Cells Sales Market Share by Country in 2025
Figure 58. Europe NK Cells Revenue Market Share by Country (2020-2025)
Figure 59. Europe NK Cells Sales Market Share by Type (2020-2025)
Figure 60. Europe NK Cells Sales Market Share by Application (2020-2025)
Figure 61. Germany NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 62. France NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 63. UK NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa NK Cells Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa NK Cells Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa NK Cells Sales Market Share by Application (2020-2025)
Figure 69. Egypt NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of NK Cells in 2025
Figure 75. Manufacturing Process Analysis of NK Cells
Figure 76. Industry Chain Structure of NK Cells
Figure 77. Channels of Distribution
Figure 78. Global NK Cells Sales Market Forecast by Region (2026-2031)
Figure 79. Global NK Cells Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global NK Cells Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global NK Cells Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global NK Cells Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global NK Cells Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of NK Cells
Figure 2. NK Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NK Cells Sales Growth Rate 2020-2031 (g)
Figure 7. Global NK Cells Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. NK Cells Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. NK Cells Sales Market Share by Country/Region (2024)
Figure 10. NK Cells Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Mogamulizumab
Figure 12. Product Picture of Lorvotuzumab Mertansine
Figure 13. Product Picture of Others
Figure 14. Global NK Cells Sales Market Share by Type in 2025
Figure 15. Global NK Cells Revenue Market Share by Type (2020-2025)
Figure 16. NK Cells Consumed in Cancer
Figure 17. Global NK Cells Market: Cancer (2020-2025) & (g)
Figure 18. NK Cells Consumed in Cardiovascular Diseases
Figure 19. Global NK Cells Market: Cardiovascular Diseases (2020-2025) & (g)
Figure 20. NK Cells Consumed in Others
Figure 21. Global NK Cells Market: Others (2020-2025) & (g)
Figure 22. Global NK Cells Sale Market Share by Application (2024)
Figure 23. Global NK Cells Revenue Market Share by Application in 2025
Figure 24. NK Cells Sales by Company in 2025 (g)
Figure 25. Global NK Cells Sales Market Share by Company in 2025
Figure 26. NK Cells Revenue by Company in 2025 ($ millions)
Figure 27. Global NK Cells Revenue Market Share by Company in 2025
Figure 28. Global NK Cells Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global NK Cells Revenue Market Share by Geographic Region in 2025
Figure 30. Americas NK Cells Sales 2020-2025 (g)
Figure 31. Americas NK Cells Revenue 2020-2025 ($ millions)
Figure 32. APAC NK Cells Sales 2020-2025 (g)
Figure 33. APAC NK Cells Revenue 2020-2025 ($ millions)
Figure 34. Europe NK Cells Sales 2020-2025 (g)
Figure 35. Europe NK Cells Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa NK Cells Sales 2020-2025 (g)
Figure 37. Middle East & Africa NK Cells Revenue 2020-2025 ($ millions)
Figure 38. Americas NK Cells Sales Market Share by Country in 2025
Figure 39. Americas NK Cells Revenue Market Share by Country (2020-2025)
Figure 40. Americas NK Cells Sales Market Share by Type (2020-2025)
Figure 41. Americas NK Cells Sales Market Share by Application (2020-2025)
Figure 42. United States NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC NK Cells Sales Market Share by Region in 2025
Figure 47. APAC NK Cells Revenue Market Share by Region (2020-2025)
Figure 48. APAC NK Cells Sales Market Share by Type (2020-2025)
Figure 49. APAC NK Cells Sales Market Share by Application (2020-2025)
Figure 50. China NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 54. India NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe NK Cells Sales Market Share by Country in 2025
Figure 58. Europe NK Cells Revenue Market Share by Country (2020-2025)
Figure 59. Europe NK Cells Sales Market Share by Type (2020-2025)
Figure 60. Europe NK Cells Sales Market Share by Application (2020-2025)
Figure 61. Germany NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 62. France NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 63. UK NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa NK Cells Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa NK Cells Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa NK Cells Sales Market Share by Application (2020-2025)
Figure 69. Egypt NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries NK Cells Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of NK Cells in 2025
Figure 75. Manufacturing Process Analysis of NK Cells
Figure 76. Industry Chain Structure of NK Cells
Figure 77. Channels of Distribution
Figure 78. Global NK Cells Sales Market Forecast by Region (2026-2031)
Figure 79. Global NK Cells Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global NK Cells Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global NK Cells Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global NK Cells Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global NK Cells Revenue Market Share Forecast by Application (2026-2031)
More Publications
Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Pipeline Review, H1 2018
US$ 3,500.00
February 2018
38 pages
Cell Based Assay Market, 2012 to 2023
US$ 4,400.00
January 2018
196 pages
